2m 2m 2m 2m 2m 2m 2m
MAPLIGHT THERAPE (MPLT)
NASDAQ
$12.58-$0.45 (-3.42%)
Price as of Aug 03, 2026 11:32 AM EDT- $554.9MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
MAPLIGHT THERAPE (MPLT)
$12.58-$0.45 (-3.42%)
MPLT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.02 | ||
Change | -$1.01 (-7.20%) | ||
Open | $14.42 | ||
High | $14.99 | ||
Low | $13.00 | ||
Previous Close | $14.03 | ||
Volume | 1,149,142 | ||
30-Day Average Volume | 1,370,533 | ||
1-Week Change | -64.39% | ||
1-Month Change | -63.67% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 42.6M | ||
Total Assets | $418.8M | ||
Market Cap | $554.9M | ||
Enterprise Value | $499.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$60.7M | ||
Free Cash Flow | -$51.2M | ||
EBIT | -$60.7M | ||
EBITDA | -$60.5M | ||
Net Working Capital | N/A | ||
EPS | -$1.34 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue